Feedback / Questions
eblasakimab (ASLAN004) - ASLAN Pharma
https://www.globenewswire.com/news-release/2022/01/18/2368447/0/en/ASLAN-Pharmaceuticals-to-Host-New-Episode-in-A4-KOL-Series-Aspects-of-Atopic-Dermatitis-and-ASLAN004.html
Jan 18, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next